OC
MLAB icon

Oppenheimer & Co’s Mesa Laboratories MLAB Stock Holding History

Oppenheimer & Co’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,475
Closed -$208K – 1466
2014
Q2 		$208K Hold
2,475
– – 0.01% 1242
2014
Q1 		$223K Sell
2,475
-81
-3% -$6.88K 0.01% 1184
2013
Q4 		$201K Buy
+2,556
New +$186K 0.01% 1211

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Oppenheimer & Co's MLAB Position: Q3 2014 in Review

Oppenheimer & Co sold out of Mesa Laboratories (MLAB) in Q3 2014, closing a stake of 2,475 shares — an estimated $208K sold.

Oppenheimer & Co first reported a position in MLAB in Q4 2013 and held it in 3 quarters. The position peaked at $223K in Q1 2014. 58 funds tracked by Wall St. Rank hold MLAB as of Q3 2014.

  • Oppenheimer & Co reported no remaining Mesa Laboratories position as of Q3 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 2,475 Mesa Laboratories shares in Q3 2014, an estimated $208K.
  • Oppenheimer & Co first reported a position in Mesa Laboratories in Q4 2013 and held it in 3 quarters.
  • Oppenheimer & Co's Mesa Laboratories position peaked at $223K in Q1 2014.
  • 58 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2014.

Based on Oppenheimer & Co's 13F filing for Q3 2014, filed 12 Nov 2014.